Computer-aided detection (CAD) and radiation therapy firm iCAD is poised to offer 2.4 million shares of common stock at $11 per share.
The offering is expected to close on or near March 17, subject to certain closing conditions.
The net proceeds are expected to be approximately $24.5 million, which the company intends to use for working capital and other general corporate purposes.
